Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...
Findings highlight the importance of infection prevention measures and personalized heart failure care.
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback